EU for Evibodies
By Kate McDonald
Monday, 09 February, 2009
Monday, 09 February, 2009
Arana Therapeutics has been granted an EU patent for its Evibodies range of small antibodies.
Evibodies were part of the technology platform brought into the company by EvoGenix when it merged with Peptech in 2007.
Evibodies are small fragments of a family of proteins that act like antibodies but are about one-tenth smaller.
They were given a US patent in 2007.
Related News
Bacteriophage cocktail to combat superbugs
Entelli-02 is a five-phage cocktail designed specifically to target Enterobacter cloacae...
Exclusive colostrum intake may reduce risk of food allergies
Newborns who are exclusively fed colostrum in the first 72 hours following birth are five times...
Sunscreen and supplements can lower your vitamin D levels
People who use SPF50+ sunscreen daily are more likely to be vitamin D deficient, while taking...
